Azione NVSEF NOVARTIS AG
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Società Novartis AG OTC Markets

Azioni

NVSEF

CH0012005267

Prodotti farmaceutici

Mercato chiuso - OTC Markets
Altri mercati azionari
 15:30:07 13/05/2024 		Variaz. 5gg Var. 1 gen.
102 USD +0,01% Grafico intraday di Novartis AG +5,95% +2,00%
13/05 Borsa svizzera: chiude in rialzo, SMI +0,12% AW
10/05 Borsa svizzera: chiusura in rialzo, SMI +1,31% AW

Attività

Novartis AG è uno dei leader mondiali nella progettazione, produzione e commercializzazione di prodotti farmaceutici. Le vendite nette (escluse le attività cessate) sono suddivise per area terapeutica come segue:
- oncologia (29,9%);
- immunologia (17,2%);
- malattie cardiovascolari, renali e metaboliche (14,1%);
- neuroscienze (8,9%).
Le vendite nette rimanenti (29,9%) derivano dalla produzione a contratto di prodotti farmaceutici.
Alla fine del 2023, Novartis AG aveva 33 siti di produzione in tutto il mondo.
Le vendite nette sono distribuite geograficamente come segue: Europa (33%), Stati Uniti (39,5%), Asia/Africa/Australasia (20,5%), Canada e America Latina (7%).

Numero di dipendenti: 76 057

Vendite per attività

CHF in Milioni2022Peso2023Peso Delta
Established Brands
30,0 %
- - 12 238 30,0 % -
Oncology
29,9 %
- - 12 213 29,9 % -
Immunology
17,2 %
- - 7 008 17,2 % -
Cardiovascular, Renal and Metabolic
14,1 %
- - 5 743 14,1 % -
Neuroscience
8,9 %
- - 3 633 8,9 % -

Vendite per regione

CHF in Milioni2022Peso2023Peso Delta
United States
39,5 %
16 860 34,9 % 16 139 39,5 % -4,28%
Europe
18,9 %
10 469 21,7 % 7 704 18,9 % -26,41%
Asia/Africa/Australasia
9,1 %
4 975 10,3 % 3 700 9,1 % -25,63%
Germany
7,4 %
4 086 8,5 % 3 026 7,4 % -25,94%
China
7,2 %
2 987 6,2 % 2 936 7,2 % -1,73%
Canada and Latin America
7,0 %
3 709 7,7 % 2 854 7,0 % -23,04%
Japan
4,2 %
2 106 4,4 % 1 729 4,2 % -17,90%
France
3,8 %
2 156 4,5 % 1 572 3,8 % -27,09%
Switzerland
2,9 %
926 1,9 % 1 175 2,9 % +26,88%

Dirigenti

Dirigenti TitoloEtàDa
Vasant Narasimhan CEO
 Chief Executive Officer 48 01/01/05
Harry Werner Kirsch DFI
 Director of Finance/CFO 59 01/01/03
Shreeram Aradhye CTO
 Chief Tech/Sci/R&D Officer 62 16/05/22
Steffen Lang COO
 Chief Operating Officer 57 01/04/17
Klaus Moosmayer CMP
 Compliance Officer 56 01/12/18
Samir Shah IRO
 Public Communications Contact 63 01/01/04
Simon Brown PRN
 Corporate Officer/Principal - 01/08/13
Kees Roks AUD
 Comptroller/Controller/Auditor 61 01/05/22
Linda Kanitra PRN
 Corporate Officer/Principal - -
Robert Kowalski HRO
 Human Resources Officer 56 01/09/21

Amministratori

Amministratori TitoloEtàDa
Bill Winters BRD
 Director/Board Member 62 01/01/13
Simon Moroney BRD
 Director/Board Member 65 28/02/20
Hans Jörg Reinhardt CHM
 Chairman 68 01/01/13
John Young BRD
 Director/Board Member 60 07/03/23
Bridgette Heller BRD
 Director/Board Member 62 28/02/20
Ton Büchner BRD
 Director/Board Member 59 01/01/16
Charles Sawyers BRD
 Director/Board Member 65 01/01/13
Nancy Andrews BRD
 Director/Board Member 65 01/01/15
Patrice Bula BRD
 Director/Board Member 68 28/02/19
Frans van Houten BRD
 Director/Board Member 64 28/02/17

Classe di azioni

VotoQuantitàFlottanteAutocontrolloFlottante totale
Azione A 1 2 189 930 497 1 866 336 959 ( 85,22 %) 233 443 766 ( 10,66 %) 85,22 %

Azionisti

NomeAzioni%Valorizzazione
NOVARTIS AG
6,625 %
145 083 991 6,625 % 14 087 M $
Sandoz Family Foundation
4,070 %
89 135 960 4,070 % 8 655 M $
UBS Asset Management Switzerland AG
3,123 %
68 391 910 3,123 % 6 640 M $
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0,3011 %
6 593 896 0,3011 % 640 M $
State Street Global Advisors Ltd.
0,2104 %
4 607 942 0,2104 % 447 M $
UBS AG (Investment Management)
0,1782 %
3 902 170 0,1782 % 379 M $
MFS International (UK) Ltd.
0,1780 %
3 899 024 0,1780 % 379 M $
La Mondiale SAM (Investment Portfolio)
0,1776 %
3 888 630 0,1776 % 378 M $
MFS International Singapore Pte. Ltd.
0,1715 %
3 755 587 0,1715 % 365 M $
Union Investment Privatfonds GmbH
0,1659 %
3 632 402 0,1659 % 353 M $
NomeAzioni%Valorizzazione
Dodge & Cox
0,6012 %
13 165 538 0,6012 % 1 304 M $
PRIMECAP Management Co.
0,5893 %
12 905 697 0,5893 % 1 278 M $
Eaton Vance Management
0,3239 %
7 092 253 0,3239 % 703 M $
Dimensional Fund Advisors LP
0,2748 %
6 018 082 0,2748 % 596 M $
Loomis, Sayles & Co. LP
0,2744 %
6 009 900 0,2744 % 595 M $
Fiduciary Trust Company International
0,2701 %
5 915 750 0,2701 % 586 M $
U.S. Trust Company of Delaware
0,2392 %
5 237 312 0,2392 % 519 M $
Wellington Management Co. LLP
0,2167 %
4 746 599 0,2167 % 470 M $
Wells Fargo Bank NA
0,1827 %
4 001 512 0,1827 % 396 M $
The Ayco Co. LP
0,1615 %
3 535 902 0,1615 % 350 M $
NomeAzioni%Valorizzazione
LUKB Expert Fondsleitung AG
-
64 694 - 6 M $
ATP Fondsmaeglerselskab A/S
-
46 082 - 5 M $
Swiss Rock Asset Management AG
-
19 614 - 2 M $
Niederer & Partners AG
-
5 300 - 517 893 $
JPMorgan Asset Management (China) Co Ltd.
-
2 652 - 259 142 $
Liontrust Portfolio Management Ltd.
-
474 - 46 317 $

Partecipazioni

NomeAzioni%Valorizzazione
NOVARTIS AG
6.63%
 145 083 991 6.63% 14 086 822 744 $
SANDOZ GROUP AG
4.30%
 18 524 209 4.30% 629 154 567 $
MORPHOSYS AG
11.56%
 4 360 100 11.56% 308 626 844 $
NOVARTIS INDIA LIMITED
70.68%
 17 450 680 70.68% 216 480 572 $
THIRD HARMONIC BIO, INC.
6.48%
 2 642 762 6.48% 27 643 291 $
ERASCA, INC.
8.12%
 12 307 692 8.12% 23 138 461 $
OCULIS HOLDING AG
4.68%
 1 713 521 4.68% 20 476 576 $
MOLECULAR PARTNERS AG
4.78%
 1 739 130 4.78% 6 238 607 $
PRECISION BIOSCIENCES, INC.
5.98%
 413 581 5.98% 4 020 007 $
GAMIDA CELL LTD.
2.82%
 4 336 759 2.82% 78 062 $

Coordinate società

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com
Indirizzo Novartis AG(NVSEF)

Società del gruppo

NomeCategoria e settore
Novartis Healthcare Pvt Ltd.
Logo Novartis Healthcare Pvt Ltd.

Novartis Healthcare Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The private company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.

Pharmaceuticals: Major
Novartis Services, Inc.
Novartis International AG
Logo Novartis International AG

Novartis International AG

Pharmaceuticals: MajorHealth Technology

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Pharmaceuticals: Major
Novartis Pharma AG
Logo Novartis Pharma AG

Novartis Pharma AG

Pharmaceuticals: MajorHealth Technology

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Pharmaceuticals: Major
Novartis Pharma GmbH
Logo Novartis Pharma GmbH

Novartis Pharma GmbH

Pharmaceuticals: MajorHealth Technology

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Pharmaceuticals: Major
Sandoz GmbH
Logo Sandoz GmbH

Sandoz GmbH

Pharmaceuticals: MajorHealth Technology

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Pharmaceuticals: Major
Alcon Ophthalmika GmbH
EBEWE Pharma Ges.m.b.H. Nfg.KG
Logo EBEWE Pharma Ges.m.b.H. Nfg.KG

EBEWE Pharma Ges.m.b.H. Nfg.KG

Pharmaceuticals: MajorHealth Technology

EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria.

Pharmaceuticals: Major
NOVARTIS INDIA LIMITED
Pharmaceuticals: Major

Settore

Sanità
Biotecnologia/Farmaceutici
Biotecnologia/Farmaceutici
Prodotti farmaceutici
Prodotti farmaceutici - Altri

Vendite per attività

Vendite per regione

Rating per Novartis AG

Rating Trading
Rating Investimento
ESG Refinitiv
Altri rating

Consensus Analisti

Vendita
Consenso
Buy
Raccomandazione media
Accumulate
Numero di analisti
20
Ultimo prezzo di chiusura
103,2 USD
Prezzo obiettivo medio
108,5 USD
Differenza / Target Medio
+5,17%
Consenso

Revisioni EPS

Revisioni delle Stime

Utili trimestrali - Indice di sorpresa

Calendario della società

Settore Prodotti farmaceutici - Altri

Variaz. 1 gen. Capi.
ELI LILLY AND COMPANY Azione Eli Lilly and Company
+31,06% 682 Mrd
NOVO NORDISK A/S Azione Novo Nordisk A/S
+30,35% 586 Mrd
JOHNSON & JOHNSON Azione Johnson & Johnson
-3,42% 364 Mrd
MERCK & CO., INC. Azione Merck & Co., Inc.
+18,02% 327 Mrd
ABBVIE INC. Azione AbbVie Inc.
+4,27% 285 Mrd
ASTRAZENECA PLC Azione AstraZeneca PLC
+15,53% 240 Mrd
ROCHE HOLDING AG Azione Roche Holding AG
-8,14% 203 Mrd
AMGEN INC. Azione Amgen Inc.
+8,12% 165 Mrd
PFIZER, INC. Azione Pfizer, Inc.
-1,42% 161 Mrd
Prodotti farmaceutici - Altri
  1. Borsa valori
  2. Azioni
  3. Azione NOVN
  4. Azione NVSEF
  5. Società Novartis AG